Bacterial lysate OM-85 prevents respiratory infections in young children

AI Insight

This randomized, placebo-controlled trial investigated whether oral administration of the bacterial lysate OM-85 in early childhood could prevent wheezing lower respiratory tract illnesses in high-risk preschool children. The study found that OM-85 did not reduce the incidence of wheezing respiratory illnesses in this population. The results indicate that bacterial lysates are not effective for primary prevention of asthma-like symptoms during the preschool years.

Why it matters

This research addresses an important clinical question about preventing respiratory illnesses in young children at high risk for developing asthma. The negative findings suggest that clinicians and parents should not rely on bacterial lysates like OM-85 as a preventive strategy for wheezing illnesses in preschoolers, helping to avoid ineffective treatments and guide resources toward more promising interventions.